During the past decade, Mercy Oncology Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator, "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Oncology Center" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (2 trials), "ALK Gene Rearrangement" (1 trials) and "ALK Gene Translocation" (1 trials). Many other conditions were trialed in "Mercy Oncology Center" in a lesser frequency.

Most popular intervention types in "Mercy Oncology Center" are "Other" (7 trials), "Drug" (5 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Computed Tomography" (3 trials), "Paclitaxel" (3 trials), "Pembrolizumab" (3 trials) and "Biospecimen Collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Oncology Center" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Oncology Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mercy Oncology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Oncology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".